MEDILARM
US Patented Technology for Patient Medication Reminders
Easy Installation
Pharmacies install color coded dosage MEDILARM on medication
Convenient Reminders
MEDILARM Patient Reminder is persistent and can't be removed until medication is taken.
Fits Any Schedule
MEDILARM is adjustable for patient and medication dosage and schedule.
About MEDILARM
MEDILARM, trademarked and patented technology by MEDiSPOSE - built with artificial intelligence technology designed for patient dosage compliance using audible and visual reminders installed on each medication package.
Our Team
Patrick M. Thibodaux - President/Managing Partner
Robert Morella, CPA – CFO
Melissa Robichaux – Comptroller
James Palmer P.E.– Director of R&D
Troy Martin M.D. – Consulting Partner
Bryan LeBean M.D. – Consulting Partner
Mohit Srivastava M.D. – Consulting Partner
Robert Morella, CPA – CFO
Melissa Robichaux – Comptroller
James Palmer P.E.– Director of R&D
Troy Martin M.D. – Consulting Partner
Bryan LeBean M.D. – Consulting Partner
Mohit Srivastava M.D. – Consulting Partner
Microcontroller Unit
The low-power brain, configurable for any prescription schedule
Battery-Powered
Up to 3 months of operation by coin cell battery
Touch Sensor
Allows patient to acknowledge and silence alarm
Piezo Speaker
Low-frequency tone for patients with diminished hearing capacity
Photo Sensor
Able to detect refrigerator being opened by patient
LED Flasher
Offers additional visual cue during alarm mode
How it Works
Why MEDILARM
The Adherence Problem
- $290 billion in health care spending
- 1/3 of prescriptions not filled
- $250 billion lost annually in potential pharma revenue
- 36% non-compliance rate
- Results in 10% of all hospitalizations
- Linked to approximately 125,000 deaths per year
The Cost
- Fewer filled prescriptions
- Increased costs to insurance providers
- Taxpayer liability from Medicare Cost
- Detriments to patient’s health
Failure of Current Reminder Methods
The best available reminders are cellphone alarms controlled by the patient.MEDILARM
Solution controls the patient, because it will not turn off until patient takes the medication.Validation Study
For a 2-month continuation study, 200 patients were prescribed refrigerated injectable medications. Below are their testimonials.
“First time I have ever been consistent taking my medication regularly.” – Anna C.
“It’s liberating knowing I can have a reminder that is NOT my children” – Mona R.
“I can’t be without this now, it’s a game changer.” – Dedrick M.
Savings for Pharmacy Benefit Managers
- 3 million annual refrigerated injectable prescriptions in Louisiana
- 200 million US national estimate per year
- Injectable Cost Range ($600 to $4500)
- $300 million revenue shortfall from 36% noncompliance
- MEDILARM Cost to PBM = $9.50 per prescription